How Manuka Honey Might Help with Breast Cancer? Insights and Research

Published On 2024-08-29 03:15 GMT   |   Update On 2024-08-29 10:00 GMT
Advertisement

A recent study reported in the Journal Nutrients outlined the promising role of Manuka Honey, in the prevention and treatment of breast cancer.

In 2022, approximately 2.3 million women globally were diagnosed with breast cancer, which ranks as the second most prevalent cancer worldwide. Around 80% of breast cancer cases are estrogen receptor-positive (ER-positive), indicating that the cancer cells have receptors that attach to estrogen and may depend on the hormone for their growth.

Advertisement

Treatment options for estrogen receptor-positive breast cancer currently include surgery, chemotherapy, radiation therapy, and hormonal therapy. Previous research has also explored complementary and alternative medicine (CAM) for treating estrogen receptor-positive breast cancer. This includes antioxidant supplements, yoga, mindfulness practices, and acupuncture.

Current studies now suggest that Manuka honey might serve as an alternative prevention and treatment option for breast cancer, especially estrogen receptor -positive breast cancer, based on studies using animal and cancer cell models.

Manuka honey is produced by bees that gather nectar from the Manuka tree, native to Australia and New Zealand.

In this study, researchers employed both mouse and breast cancer cell models to investigate the effects of Manuka honey on breast cancer. They discovered that Manuka honey led to an 84% reduction in tumour growth in mice with estrogen receptor -positive breast cancer cells, while not adversely affecting healthy breast cells or causing significant side effects.

Scientists found that higher quantities of Manuka honey were linked to a more significant decrease in cancer cell growth. Furthermore, the research indicated that Manuka honey helped lower the activity of signaling pathways commonly elevated in cancer, such as AMP-activated protein kinase (AMPK), Ak strain transforming (AKT), mammalian target of rapamycin (mTOR), and signal transducer and activator of transcription 3 (STAT3), all of which are involved in tumor cell growth and survival.

Reference: Márquez-Garbán DC, Yanes CD, Llarena G, Elashoff D, Hamilton N, Hardy M, Wadehra M, McCloskey SA, Pietras RJ. Manuka Honey Inhibits Human Breast Cancer Progression in Preclinical Models. Nutrients. 2024; 16(14):2369. https://doi.org/10.3390/nu16142369

Full View
Tags:    
Article Source : Nutrients Journal

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News